Search the Newsreel

Entera Bio Leads Our Top 3 Penny Stocks To Consider

This article identifies three penny stocks—Entera Bio (ENTX), Vuzix (VUZI), and MacroGenics (MGNX)—that show potential for growth despite their current financial challenges. Entera Bio, a clinical-stage biotech company, is advancing towards Phase 3 trials for its osteoporosis treatment. Vuzix, an AI-powered smart glasses manufacturer, …

Entera Bio Gains 3.57% as Stock Approaches Key Resistance Level (ENTX) - Growth Factor

Entera Bio Stock Rallies 35% in a Month: Here's What You Should Know

Entera Bio (ENTX) shares have surged 34.5% in the past month due to positive FDA feedback on the Phase III study design for its lead candidate, EB613, an oral treatment for postmenopausal osteoporosis. The FDA supports a single 12-month Phase III study, which could …

Entera Bio (NASDAQ: ENTX) CEO swaps cash for stock-settled RSUs

Entera Bio's CEO, Toledano Miranda Jayne, received two grants of stock-settled Restricted Stock Units (RSUs) on July 14, 2026, in lieu of cash compensation. One grant, totaling 72,993 ordinary shares, replaced her 2025 annual cash bonus, while the other, for 347,567 shares, substituted $100,000 …

Entera Bio (NASDAQ: ENTX) expands share authorization and equity plan pool

Entera Bio (NASDAQ: ENTX) shareholders approved an increase in the authorized ordinary shares from 140,010,000 to 350,000,000 and added 2,500,000 ordinary shares to the 2018 Equity Incentive Plan. These approvals were made during the company's 2026 Annual Meeting, alongside the re-election of Class III …

Entera Bio shareholders approve authorized share increase at annual meeting

Entera Bio shareholders approved an increase in authorized ordinary shares from 140,010,000 to 350,000,000 at their 2026 annual meeting on July 14, 2026. They also adopted a one-time increase of 2,500,000 ordinary shares for the 2018 Equity Incentive Plan and ratified Kesselman & Kesselman …

Entera Bio Ltd. (ENTX) Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Market Reaction - Profit Warning Alert

ENTX Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Double-Digit Stock Rally - Earnings Turnaround

TalentX Inc. FY2025 通期決算説明会

Is Entera Bio (NASDAQ:ENTX) In A Good Position To Invest In Growth?

Entera Bio Ltd. Earnings and Revenue – NASDAQ:ENTX